The addition of clofarabine to standard induction therapy for newly diagnosed acute myeloblastic leukemia reduced the probably of relapse but increased toxicity and had no effect on survival. (Source: CancerNetwork)
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iw4ssj
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Own a website? Manage your page to keep your users updated View some of our premium pages: . . . . Upgrade to a Premium Page from #Alexand...
-
Nous voudrions effectuer une description ici mais le site que vous consultez ne nous en laisse pas la possibilité. from #AlexandrosSfakian...
-
by Hyeon-Su Jin, Seon Yeong Park, Kyungmin Kim, Yong-Jik Lee, Gae-Won Nam, Nam Joo Kang, Dong-Woo Lee Poultry feathers consist mainly of th...
-
Abstract Purpose of Review Knee and hip osteoarthritis (OA) are major public health problems worldwide causing pain, disability and impa...
-
Abstract Purpose of the review Treat to Target (T2T) strategy has been widely used in the management of chronic medical conditions, such...
-
by Thore M. Bücking, Emma R. Hill, James L. Robertson, Efthymios Maneas, Andrew A. Plumb, Daniil I. Nikitichev Anatomical models are import...
-
by Patrick P. Lowe, Benedek Gyongyosi, Abhishek Satishchandran, Arvin Iracheta-Vellve, Aditya Ambade, Yeonhee Cho, Karen Kodys, Donna Catala...
-
Radiation Research, Volume 187, Issue 6 , Page 647-658, June 2017. from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nSFDFE via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου